Scientific Solutions
  • Home
  • Insights
  • Scientific Solutions

Scientific Solutions

Drug Safety Evaluation in Adult Zebrafish

Accelerate early toxicity screening with a cost-effective, high-throughput vertebrate model that integrates behavioral, histopathological, and biochemical endpoints to identify neurotoxic and systemic risks before advancing to mammalian studies.

Preclinical Safety Services

Gene Expression and Signaling Studies in Zebrafish

Validate molecular targets, elucidate signaling cascades, and quantify gene expression changes in a high-throughput in vivo vertebrate model. Our zebrafish platform enables rapid, cost-effective assessment of inflammation, muscle health, and disease pathways with direct translational relevance.

Molecular Mechanism Research Services

Accelerate Drug Discovery with Clinically Relevant Zebrafish Models

Our Zebrafish Disease Model Construction Service provides end-to-end support for creating genetically defined models that recapitulate human disease pathology.

Zebrafish Disease Model Construction Service

Accelerate Lead Prioritization with Whole-Organism In Vivo Efficacy Data

The zebrafish (Danio rerio) model bridges the gap between in vitro assays and mammalian studies, offering a whole-organism context that reveals systemic drug effects – from target engagement to behavioral and metabolic outcomes.

Pharmacodynamic Evaluation In Zebrafish

Accelerate Translational Research with Predictive Zebrafish Efficacy Models

Zebrafish (Danio rerio) have emerged as a powerful vertebrate model for preclinical efficacy testing, offering a unique combination of optical transparency, high fecundity, and genetic homology to humans—approximately 70% of human disease genes have a zebrafish orthologue.

Zebrafish Disease Model Service

Discover Neuroactive Compounds with Whole-Organism Behavioral Readouts

The larval zebrafish (Danio rerio) has become a powerful vertebrate model for identifying compounds that modulate nervous system activity.

In Vivo Neuroactivity Screening

High-Throughput Screening for Skin-Whitening & Pigment-Modulating Compounds

Cosmetic ingredient developers and pharmaceutical teams face a common challenge: cell-based assays lack whole-organism context, yet mammalian models are slow and costly for early-stage screening.

Zebrafish Pigmentation Screening Service

Liver Toxicity Screening Service

Drug-induced liver injury (DILI) remains a leading cause of attrition during both early and late-stage drug development, as well as post-marketing withdrawals.

In Vivo Zebrafish Hepatotoxicity Screening

Parkinson's Disease Model & Efficacy Evaluation

Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by the selective loss of dopaminergic neurons in the brain.

Zebrafish Disease Model

Quantify Pigment Modulation with Integrated In Vitro and Zebrafish Models

Our service provides quantitative readouts of melanocyte differentiation and melanin production, critical for evaluating compounds targeting pigmentation pathways.

Melanocyte Differentiation & Melanin Detection

Visualize Neuronal Activity in Real Time

In vivo calcium imaging enables direct visualization of neuronal activity by recording fluorescence changes from genetically encoded calcium indicators (GECIs) such as GCaMP6s.

In Vivo Calcium Imaging & Neural Circuit Analysis

Zebrafish Developmental Toxicity Evaluation Service

Identifying developmental toxicity risks early in drug and chemical development is critical to avoid costly late-stage failures.

Preclinical Toxicology Screening

Zebrafish Disease Modeling: Accelerate Target Validation and Drug Discovery

Zebrafish (Danio rerio) have become a cornerstone of preclinical drug discovery, offering a unique balance between the genetic tractability of invertebrate models and the physiological complexity of rodents.

Translational Model Services

Zebrafish Embryo Developmental Toxicity Assay

Each year, thousands of compounds must be screened for developmental toxicity during pharmaceutical and chemical development.

Whole-Organism Developmental Toxicity Screening

Zebrafish Retinal Toxicity Assessment

Retinal toxicity remains a leading cause of late-stage attrition in ophthalmic drug development. Standard rodent models, though predictive, are slow and resource-intensive, often delaying candidate selection.

In Vivo Ocular Safety Screening
Quick Inquiry

Tell Us What Happened

Please contact us if you have questions about our company, our products, or general enquiries.

Please use the form.